Esophageal and Esophagogastric Junction Cancers, version 2.2019, NCCN Clinical Practice Guidelines in Oncology Guidelines

  


Authors: Ajani, J. A.; D'Amico, T. A.; Bentrem, D. J.; Chao, J.; Corvera, C.; Das, P.; Denlinger, C. S.; Enzinger, P. C.; Fanta, P.; Farjah, F.; Gerdes, H.; Gibson, M.; Glasgow, R. E.; Hayman, J. A.; Hochwald, S.; Hofstetter, W. L.; Ilson, D. H.; Jaroszewski, D.; Johung, K. L.; Keswani, R. N.; Kleinberg, L. R.; Leong, S.; Ly, Q. P.; Matkowskyj, K. A.; McNamara, M.; Mulcahy, M. F.; Paluri, R. K.; Park, H.; Perry, K. A.; Pimiento, J.; Poultsides, G. A.; Roses, R.; Strong, V. E.; Wiesner, G.; Willett, C. G.; Wright, C. D.; McMillian, N. R.; Pluchino, L. A.
Title: Esophageal and Esophagogastric Junction Cancers, version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Abstract: Esophageal cancer is the sixth leading cause of cancer-related deaths worldwide. Squamous cell carcinoma is the most common histology in Eastern Europe and Asia, and adenocarcinoma is most common in North America and Western Europe. Surgery is a major component of treatment of locally advanced resectable esophageal and esophagogastric junction (EGJ) cancer, and randomized trials have shown that the addition of preoperative chemoradiation or perioperative chemotherapy to surgery significantly improves survival. Targeted therapies including trastuzumab, ramucirumab, and pembrolizumab have produced encouraging results in the treatment of patients with advanced or metastatic disease. Multidisciplinary team management is essential for all patients with esophageal and EGJ cancers. This selection from the NCCN Guidelines for Esophageal and Esophagogastric Junction Cancers focuses on recommendations for the management of locally advanced and metastatic adenocarcinoma of the esophagus and EGJ.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 17
Issue: 7
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2019-07-01
Start Page: 855
End Page: 883
Language: English
DOI: 10.6004/jnccn.2019.0033
PUBMED: 31319389
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070074237&doi=10.6004%2fjnccn.2019.0033&partnerID=40&md5=457baa264c34bb44c1c56bdb75d0155b
Notes: Article -- Export Date: 4 September 2019 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Hans Gerdes
    176 Gerdes
  2. Vivian Strong
    264 Strong
  3. David H Ilson
    433 Ilson
Related MSK Work